Luckwel Pharmaceuticals Inc. Patent Applications Rejected
3 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2022-06-17: Application 17842869; Invention INJECTABLE FORMULATION OF HYDROXYCHLOROQUINE; Applicant Luckwel Pharmaceuticals Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2022-04-28: Application 17732113; Invention MINI-TABLETS IN CAPSULE DOSAGE FORM COMPRISING ATORVASTATIN; Applicant Luckwel Pharmaceuticals Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2021-06-30: Application 17364331; Invention COMBINATION THERAPY FOR TREATING COVID-19; Applicant Luckwel Pharmaceuticals Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2022-06-17 | 17842869 | INJECTABLE FORMULATION OF HYDROXYCHLOROQUINE | Luckwel Pharmaceuticals Inc. | Abandoned -- Incomplete Application (Pre-examination) | US20220409609A1 | Kingrich Lee | United States | |
| 2022-04-28 | 17732113 | MINI-TABLETS IN CAPSULE DOSAGE FORM COMPRISING ATORVASTATIN | Luckwel Pharmaceuticals Inc. | Abandoned -- Incomplete Application (Pre-examination) | US20220362210A1 | Kingrich Lee | United States | |
| 2021-06-30 | 17364331 | COMBINATION THERAPY FOR TREATING COVID-19 | Luckwel Pharmaceuticals Inc. | Abandoned -- Failure to Respond to an Office Action | US20230000884A1 | Kingrich Lee | United States | HOWELL, THEODORE R |